AGP Executive Report
Last update: 5 hours agoBiotech Deal: SERB Pharmaceuticals has signed to buy exclusive development and commercialisation rights to Idefirix (imlifidase) from Hansa Biopharma for €115m ($133.6m), covering the EU plus Liechtenstein, Norway, Switzerland, the UK and MENA—Hansa gets €110m upfront and another €5m after the EMA accepts the full filing, with completion expected within 60 days. Diplomacy & Energy: Prime Minister Narendra Modi is pushing a green-and-trade agenda across Northern Europe, meeting Iceland, Finland and Denmark in Oslo ahead of the India–Nordic Summit, with talks focused on clean energy, sustainability and digital cooperation. Arts & Design in Liechtenstein-linked culture: Schloss Hollenegg for Design is spotlighting contemporary work through the castle’s “Element: Metal” theme, bringing new material-led exhibitions into the Liechtenstein family’s historic Austrian setting. Sports & Culture Calendar: Co Armagh is set to host Northern Ireland’s first CEV Small Countries Association Men’s Senior Championship, with Liechtenstein among the participating teams.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
